Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine in Recurrent Implantation Failure
NCT03498703Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azathioprine in Recurrent Implantation Failure (RIF), sponsored by Ain Shams University. Started Apr 2018; status: completed.
02
Drugs
azathioprine
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03498703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498703.